Contact
searchSearch
HMP Global

Psoriasis Topic Center

Featured

psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
psoriasis
News
Primary Biliary Cirrhosis and Psoriasis Co-Occurrence
09/19/2024
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the...
09/19/2024
The Dermatologist
psoriasis
News
Long-Term Risankizumab Treatment for Moderate to Severe Plaque Psoriasis
08/22/2024
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the...
08/22/2024
The Dermatologist
psoriasis
News
Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
07/26/2024
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from...
07/26/2024
The Dermatologist
psoriasis
News
Overlap Phenotype Between Psoriasis and Atopic Dermatitis
07/18/2024
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene...
07/18/2024
The Dermatologist
psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
psoriasis
News
PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis
06/24/2024
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
psorasis
News
Association Between Fatty Acids and Psoriasis Development
05/14/2024
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate...
05/14/2024
The Dermatologist

News & FDA Alerts

psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
psoriasis
News
Primary Biliary Cirrhosis and Psoriasis Co-Occurrence
09/19/2024
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the...
09/19/2024
The Dermatologist
psoriasis
News
Long-Term Risankizumab Treatment for Moderate to Severe Plaque Psoriasis
08/22/2024
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the...
08/22/2024
The Dermatologist
psoriasis
News
Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
07/26/2024
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from...
07/26/2024
The Dermatologist
psoriasis
News
Overlap Phenotype Between Psoriasis and Atopic Dermatitis
07/18/2024
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene...
07/18/2024
The Dermatologist
psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
psoriasis
News
PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis
06/24/2024
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
psorasis
News
Association Between Fatty Acids and Psoriasis Development
05/14/2024
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate...
05/14/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
psoriatic arthritis
News
Early Diagnosis May Be Crucial for Psoriatic Arthritis
09/25/2024
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic...
09/25/2024
The Dermatologist
PsA
FDA Alerts
Bimekizumab FDA Approved for the Treatment of Psoriatic Arthritis
09/24/2024
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug...
09/24/2024
The Dermatologist
acne
News
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
09/19/2024
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in...
09/19/2024
The Dermatologist
psoriasis
News
Primary Biliary Cirrhosis and Psoriasis Co-Occurrence
09/19/2024
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the...
09/19/2024
The Dermatologist
atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
acne
News
Targeted Precision Cryotherapy Treatment for Acne Lesions
09/11/2024
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial...
09/11/2024
The Dermatologist

Endorsed Articles

Partner Approved
Unilateral Linear Psoriasis: A Case Report
05/13/2020
A 19-year-old white woman with a 4-year history of a rash localized to her left arm and hand. The lesion started as a small plaque on her forearm and gradually spread in a linear fashion from her fingertip to her upper arm.
A 19-year-old white woman with a 4-year history of a rash localized to her left arm and hand. The lesion started as a small plaque on her forearm and gradually spread in a linear fashion from her fingertip to her upper arm.
A 19-year-old white woman with a...
05/13/2020
The Dermatologist
Disease Management and Patient Care Recommendations During the COVID-19 Pandemic
Partner Approved
Disease Management and Patient Care Recommendations During the COVID-19 Pandemic
04/14/2020
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass...
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass...
Patients with psoriasis and...
04/14/2020
The Dermatologist
Options With IL-23 Inhibitors for the Patient With Psoriasis
NPF Endorsed Features
Options With IL-23 Inhibitors for the Patient With Psoriasis
03/12/2020
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such...
03/12/2020
The Dermatologist
Management of Psoriasis in Adolescents
Partner Approved
Management of Psoriasis in Adolescents
01/16/2020
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term...
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term...
...
01/16/2020
The Dermatologist
NPF Endorsed Features
Patient Enrollment Completed for Second Phase III Clinical Trial in Psoriasis Program
12/18/2015
Dermira, Inc., a specialty biopharmaceutical company, announced the completion of patient enrollment for the global CIMPASI-1 clinical trial of certolizumab pegol (Cimzia, UCB Inc.) in adult patients with moderate-to-severe chronic plaque...
Dermira, Inc., a specialty biopharmaceutical company, announced the completion of patient enrollment for the global CIMPASI-1 clinical trial of certolizumab pegol (Cimzia, UCB Inc.) in adult patients with moderate-to-severe chronic plaque...
Dermira, Inc., a specialty...
12/18/2015
The Dermatologist
NPF Endorsed Features
Study Links Psoriasis to Higher PsA Risk
12/18/2015
New research finds the incidence of psoriatic arthritis (PsA) among patients with psoriasis is much greater than previously thought.
New research finds the incidence of psoriatic arthritis (PsA) among patients with psoriasis is much greater than previously thought.
New research finds the incidence...
12/18/2015
The Dermatologist
NPF Endorsed Features
The Biologic Revolution in Treatment of Psoriasis and PsA
12/18/2015
  This article reviews the current biologic therapies for the treatment of psoriasis and psoriatic arthritis, discusses the importance of patient and clinician education in the decision-making process and highlights drugs in the...
  This article reviews the current biologic therapies for the treatment of psoriasis and psoriatic arthritis, discusses the importance of patient and clinician education in the decision-making process and highlights drugs in the...
  This article reviews...
12/18/2015
The Dermatologist
NPF Endorsed Features
First Independent US Psoriasis Registry to Track Drug Safety and Effectiveness
03/18/2015
A new independent US psoriasis registry — a joint collaboration with the National Psoriasis Foundation and Corrona, LLC — will allow people with psoriasis and their healthcare providers to participate in research that aims to improve...
A new independent US psoriasis registry — a joint collaboration with the National Psoriasis Foundation and Corrona, LLC — will allow people with psoriasis and their healthcare providers to participate in research that aims to improve...
A new independent US psoriasis...
03/18/2015
The Dermatologist
NPF Endorsed Features
Increased Focus on Research in Psoriasis
10/23/2014
Thirteen early-career physicians receive National Psoriasis Foundation fellowships to study psoriasis.  
Thirteen early-career physicians receive National Psoriasis Foundation fellowships to study psoriasis.  
Thirteen early-career physicians...
10/23/2014
The Dermatologist
NPF Endorsed Features
Factors for Choosing the Right Biologic Treatment
09/19/2014
This article, based on a presentation that was given at the Interdisciplinary Autoimmune Summit held in June 2014 in Las Vegas, describes how to select the right biologic for a patient who has not previously received biologic...
This article, based on a presentation that was given at the Interdisciplinary Autoimmune Summit held in June 2014 in Las Vegas, describes how to select the right biologic for a patient who has not previously received biologic...
This article, based on a...
09/19/2014
The Dermatologist
NPF Endorsed Features
Reexamining Remission in Psoriasis
10/07/2024
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can...
10/07/2024
The Dermatologist
NPF Endorsed Features
Phone-a-Friend: Exploring the Collaborative Care Model in Psoriasis
08/06/2024
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of...
08/06/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
NPF Endorsed Features
The Mental Health and Psoriatic Disease Connection
02/07/2024
A recent National Psoriasis Foundation webinar explores the link between psychiatric comorbidities and skin conditions.
A recent National Psoriasis Foundation webinar explores the link between psychiatric comorbidities and skin conditions.
A recent National Psoriasis...
02/07/2024
The Dermatologist
NPF Endorsed Features
Understanding Generalized Pustular Psoriasis
12/05/2023
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history...
12/05/2023
The Dermatologist
NPF Endorsed Features
Psoriasis Clinical Trial Travel Challenges
10/17/2023
Being mindful of transportation as a potential barrier to obtaining care can improve patients’ quality of life.
Being mindful of transportation as a potential barrier to obtaining care can improve patients’ quality of life.
Being mindful of transportation...
10/17/2023
The Dermatologist
NPF Endorsed Features
Psoriasis in Women of Childbearing Age
09/11/2023
Women have unique considerations for the management and treatment of their psoriasis.
Women have unique considerations for the management and treatment of their psoriasis.
Women have unique considerations...
09/11/2023
The Dermatologist
NPF Endorsed Features
Telemedicine: Revolutionizing Psoriatic Disease Management
08/11/2023
The field of teledermatology has witnessed significant advancements in recent years.
The field of teledermatology has witnessed significant advancements in recent years.
The field of teledermatology has...
08/11/2023
The Dermatologist
NPF Endorsed Features
Spring Dermatology Week 2023: Psoriasis Session Roundup
06/12/2023
This multiday virtual event offered practical, timely education that attendees can immediately translate into positive patient outcomes.
This multiday virtual event offered practical, timely education that attendees can immediately translate into positive patient outcomes.
This multiday virtual event...
06/12/2023
The Dermatologist
NPF Endorsed Features
Psoriasis and Skin of Color
05/08/2023
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
Increased awareness of the...
05/08/2023
The Dermatologist

Quizzes and Polls

psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
psoriatic arthritis on hand
Quiz
Trivia: Treatment Improves Health-Related Quality of Life in Patients With Psoriatic Arthritis
08/03/2022
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved...
08/03/2022
The Dermatologist
psoriasis on hand and stomach
Quiz
Trivia: Risankizumab Comparable Safety and Efficacy Profiles in Psoriasis
06/15/2022
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and...
06/15/2022
The Dermatologist
psoriasis generalized pustular
Quiz
Trivia: Psoriasis Treatment Perspectives and Expectations
05/18/2022
Which of these options list the characteristics that impact treatment goals for patients with psoriasis?
Which of these options list the characteristics that impact treatment goals for patients with psoriasis?
Which of these options list the...
05/18/2022
The Dermatologist
psoriasis severe arm
Quiz
Trivia: Psoriasis and Stress Coping Strategies
04/05/2022
Which of the following is impacted by psoriasis and stress coping strategies ?
Which of the following is impacted by psoriasis and stress coping strategies ?
Which of the following is...
04/05/2022
The Dermatologist
psoriasis-severe
Quiz
Trivia: Unmet Needs in Psoriasis
12/02/2021
Which of the following accurately highlights what unmet needs were reported by patients with mild-to-moderate psoriasis?
Which of the following accurately highlights what unmet needs were reported by patients with mild-to-moderate psoriasis?
Which of the following...
12/02/2021
The Dermatologist
Severe psoriasis, such as plaque psoriasis shown here, can benefit from biologic agents that enable psoriasis treatment.
Quiz
Trivia: Efficacy of Biologic Agents
10/05/2021
Can you identify how dermatologists can observe the efficacy of biologic agents on the full psoriasis disease burden?
Can you identify how dermatologists can observe the efficacy of biologic agents on the full psoriasis disease burden?
Can you identify how...
10/05/2021
The Dermatologist
Patient with psoriasis on the scalp. Recent studies have looked into hypochondriasis in psoriasis such as this patient.
Quiz
Trivia: Hypochondriasis and Personality Traits in PsO
09/09/2021
An observational study of patients with psoriasis sought to assess hypochondriasis and personality traits. Can you identify which of these options describes their findings?
An observational study of patients with psoriasis sought to assess hypochondriasis and personality traits. Can you identify which of these options describes their findings?
An observational study of...
09/09/2021
The Dermatologist
A patient suffering from obesity showcasing a case of plaque psoriasis in a potential risk for cardiovascular disease.
Quiz
Trivia: Measuring Arterial Function in Patients with Psoriasis
08/26/2021
Identify what noninvasive measurement of arterial function was performed on patients with chronic plaque psoriasis to determine cardiovascular risk.
Identify what noninvasive measurement of arterial function was performed on patients with chronic plaque psoriasis to determine cardiovascular risk.
Identify what noninvasive...
08/26/2021
The Dermatologist
pediatric psoriasis pictures severe psoriasis on knees
Quiz
Trivia: Pediatric Psoriasis Comorbidities
08/23/2021
Which of these options accurately portrays the common comorbidities observed within pediatric patients with psoriasis?
Which of these options accurately portrays the common comorbidities observed within pediatric patients with psoriasis?
Which of these options...
08/23/2021
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Recent News

psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
psoriasis
News
Primary Biliary Cirrhosis and Psoriasis Co-Occurrence
09/19/2024
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the...
09/19/2024
The Dermatologist
psoriasis
News
Long-Term Risankizumab Treatment for Moderate to Severe Plaque Psoriasis
08/22/2024
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the...
08/22/2024
The Dermatologist
psoriasis
News
Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
07/26/2024
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from...
07/26/2024
The Dermatologist
psoriasis
News
Overlap Phenotype Between Psoriasis and Atopic Dermatitis
07/18/2024
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene...
07/18/2024
The Dermatologist
psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
psoriasis
News
PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis
06/24/2024
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
psorasis
News
Association Between Fatty Acids and Psoriasis Development
05/14/2024
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate the causal relationship between n-3 fatty acids levels and psoriasis using a Mendelian randomization approach.
Researchers aimed to investigate...
05/14/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
psoriatic arthritis
News
Early Diagnosis May Be Crucial for Psoriatic Arthritis
09/25/2024
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic...
09/25/2024
The Dermatologist
PsA
FDA Alerts
Bimekizumab FDA Approved for the Treatment of Psoriatic Arthritis
09/24/2024
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug...
09/24/2024
The Dermatologist
acne
News
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
09/19/2024
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in...
09/19/2024
The Dermatologist
psoriasis
News
Primary Biliary Cirrhosis and Psoriasis Co-Occurrence
09/19/2024
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
Researchers investigated the...
09/19/2024
The Dermatologist
atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
acne
News
Targeted Precision Cryotherapy Treatment for Acne Lesions
09/11/2024
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial...
09/11/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use